Discover how innovative cell culture membrane inserts from Greiner Bio-One are revolutionizing drug development. In this article Philipp Wachter explains their role in enhance high-throughput screening studies and optimizing ADME studies for better drug evaluation.
Quick decisions in blood collection are a daily challenge in healthcare. In this article we supports you in making the best possible product decisions for various patient needs.
Animal models are costly, time-consuming, and often have limited relevance to human biology. In this article, we’ll explain the advantages of magnetic 3D cell culture (M3D), why they are so useful, and how they are used in the laboratory – step-by-step.
Kremsmünster, March 13, 2024 – Kruno Obrovac has taken over the position of Chief Operating Officer (COO) at Greiner Bio-One as of
March 1, 2024.…
We are pleased to announce that Greiner Bio-One has recently become a Corporate Member of the International Federation of Clinical Chemistry and…
Votre partenaire international leader dans les domaines de la biotechnologie, du diagnostic, des dispositifs médicaux, du diagnostic in vitro ainsi que dans le monde de la recherche. Greiner Bio-One International GmbH est un acteur mondial qui compte plus de 2300 employés et 28 filiales. Nous disposons de sites de production en Autriche, en Allemagne, en Hongrie, aux États-Unis, au Brésil et en Thaïlande. Le siège de la société, qui appartient à 100 % à la famille Greiner, se trouve à Kremsmünster, en Haute-Autriche. Greiner Bio-One International est une société du groupe Greiner. Nous nous concentrons sur une forte orientation client et sur des solutions produits innovantes et de haute qualité.
We would like to direct you to the correct site for your country.
